BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Deals

  Texas A&M Institute for Regenerative Medicine and Celltex Therapeutics Enter Agreement for Alzheimer’s Research

  The announcement signals the first year of a multi-year research study investigating potential therapies for Alzheimer’s disease using autologous mesenchymal stem cell (MSC)-derived exosomes.

  February 6, 2018

   · 

  4 min read
• OncoQuest Completes US$6 Million Private Placement

  The financing was led by a South Korean institutional fund. Under the private placement, the Company issued 603,000 common shares at US$10.00 share.

  February 6, 2018

   · 

  3 min read
• TTP Labtech Collaborates With Onespacemedia for Website Redevelopment

  TTP LabTech Ltd., a global leader in the design and development of automated instrumentation and consumables for life science applications, is delighted to announce the launch of its new website.

  February 6, 2018

   · 

  2 min read
• Santhera Launches U.S. Expanded Access Program with Idebenone for Patients With Duchenne Muscular Dystrophy (DMD)

  Eligible patients with DMD who are 10 years and older and in respiratory function decline, can obtain access to investigational idebenone, at no cost, through a growing network of research centers across the U.S.

  February 6, 2018

   · 

  5 min read
• Business

  Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results

  Neurocrine Biosciences announced today that it will report fourth quarter and year-end 2017 financial results after the Nasdaq market closes on Tuesday, Feb. 13, 2018.

  February 6, 2018

   · 

  1 min read
• Business

  Eclipse’s Rapid Growth Leads to New Management

  Eclipse is proud to announce the promotion of Michael O’Brien to the position of Vice President of Sales for the United States.

  February 6, 2018

   · 

  2 min read
• Genetown

  Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Verastem today announced the grant of stock options to six new employees to purchase an aggregate of 219,000 shares of Verastem’s common stock.

  February 6, 2018

   · 

  2 min read
• Business

  Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results

  tSeattle Genetics today reported financial results for the fourth quarter and year ended December 31, 2017.

  February 6, 2018

   · 

  19 min read
• BioMidwest

  Baxter to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference

  Baxter will present at the Raymond James & Associates 39th Annual Institutional Investors Conference on Tuesday, March 6, 2018, in Orlando, Fla. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 4:35 p.m. EST.

  February 6, 2018

   · 

  1 min read
• Business

  Gilead Sciences Announces Fourth Quarter and Full Year 2017 Financial Results

  Total revenues for the fourth quarter of 2017 were $5.9 billion compared to $7.3 billion for the same period in 2016.

  February 6, 2018

   · 

  29 min read